Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT04433533
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT04433533
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT04433533. Randomized; no masking; primary purpose treatment. Start 2021-01-06 (actual); primary completion 2023-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia
- Condition
- Left Ventricular Diastolic Dysfunction
- Condition
- Hyperlipidemias
- Intervention (Drug)
- Rosuvastatin 20
- Intervention (Drug)
- Rosuvamibe 10/10
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct04433533- Content hash
12afc78ac0d0f0d00d5dbea620dd19c03d1115b75f76c2ef01450be72b12371d